Centre Increases Process Development Opportunities in Shanghai

Science and technology company Merck has opened its M Lab™ Collaboration Center in Shanghai, the company’s largest of nine centres worldwide. 

“With the booming pharmaceutical industry in Asia and greater emphasis on novel drug therapies, we see an increase in R&D on leading-edge treatments including cell and gene therapies in China,” said Udit Batra, member of the Merck Executive Board and CEO, Life Science. “Our M Lab™ Collaboration Centre offers customisable solutions and services that help bio pharmaceutical and biologics companies improve their processes from drug discovery, development to manufacturing — saving costs and increasing speed to market.”

With a total lab size of approximately 10,000m2, Merck’s newest collaboration Centre is located in Pudong, at the heart of the biomedical sciences and research community. It includes pilot scale and process development support labs that offer non-GMP (Good Manufacturing Practice) lab space where pharmaceutical and biopharmaceutical manufacturers can explore ideas, learn innovative techniques and work side-by-side with the company’s scientists and engineers to solve critical process development and production challenges.